Algernon Pharmaceuticals Stock Set to Reverse Split on Wednesday, November 24th (OTCMKTS:AGNPF)

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF)’s stock is going to reverse split on Wednesday, November 24th. The 1-100 reverse split was announced on Wednesday, November 24th. The number of shares owned by shareholders will be adjusted after the market closes on Wednesday, November 24th.

Shares of OTCMKTS AGNPF opened at $0.04 on Friday. Algernon Pharmaceuticals has a 52-week low of $0.04 and a 52-week high of $0.44. The business has a fifty day moving average of $0.06 and a two-hundred day moving average of $0.09.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of nonÂ-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia.

Read More: EV Stocks

Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.